21489 ⎘
Preparations for testing; Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier; Organic compounds; Macromolecular compounds; Linear polymers, e.g. dextran, inulin, PEG comprising multiple complex or complex-forming groups, being either part of the linear polymeric backbone or being pending groups covalently linked to the linear polymeric backbone
POLYMER CONTRAST AGENT
#2NANOSTRUCTURE EXCRETED IN URINE THROUGH KIDNEY WITHOUT BEING PHAGOCYTOSED AND/OR METABOLIZED BY MACROPHAGE AFTER IN VIVO INJECTION
#3COMPOSITIONS AND METHODS FOR TARGETING CELLS
#4NANOSTRUCTURE EXCRETED IN URINE THROUGH KIDNEY WITHOUT BEING PHAGOCYTOSED AND/OR METABOLIZED BY MACROPHAGE AFTER IN VIVO INJECTION
#5POLYSACCHARIDE COMPRISING A CHELATING GROUP SOLUBLE AT PHYSIOLOGICALPH AND USE THEREOF
#6FUNCTIONALIZED LIPOSOMES FOR IMAGING MISFOLDED PROTEINS
#7COMPOUNDS FOR USE AS IRON(III) MRI CONTRAST AGENTS
#8Compositions and methods for targeting cells
#9Nanovectors and uses
#10FUNCTIONALIZED LIPOSOMES FOR IMAGING MISFOLDED PROTEINS
#11Compounds for use as iron(III) MRI contrast agents
#12ULTRAFINE NANOPARTICLES AS AN IMAGING AGENT FOR DIAGNOSING A RENAL DISORDER
#13Lymph targeting nuclear magnetic contrast agent using brown algae polysaccharide as carrier and preparation method and use thereof
#14Defined monomer sequence polymers
#15Macromolecular delivery systems for non-invasive imaging, evaluation and treatment of arthritis and other inflammatory diseases
#16SIDE-CHAIN CRYSTALLIZABLE POLYMERS FOR MEDICAL APPLICATIONS
#17Manganese-oxo clusters as contrast agents for magnetic resonance imaging
#18ENZYME DIRECTED ASSEMBLY OF PARTICLE THERANOSTICS
#19Polymer nanoparticle composite and composition for MRI imaging including same
#20Polymeric nanocarriers with linear dual response mechanism
#21Manganese comprising nanostructures
#22Iron oxide nanocapsule, method of manufacturing the same, and MRI contrast agent using the same
#23MRI-visible hydrophobic copolymer
#24Methods and compositions for objectively characterizing medical images
#25IMAGING AGENTS OF FIBROTIC DISEASES
#26Intracellular Delivery of Contrast Agents with Functionalized Nanoparticles
#27Polymalic acid based nanoconjugates for imaging
#28Hydrophobic polymer for producing medical devices visible in MRI
#29Manganese-oxo clusters as contrast agents for magnetic resonance imaging
#30Polymeric nano-carriers with a linear dual response mechanism and uses thereof
#31Gadolinium complex, method for preparing same, and MRI contrast agent comprising same
#32Side-chain crystallizable polymers for medical applications
#33Polymer-metal complex composite having MRI contrast ability and MRI contrasting and/or antitumor composition using the same
#34Multi-Component Biological Transport Systems
#35USE OF MRI CONTRAST AGENTS FOR EVALUATING THE TREATMENT OF TUMORS
#36BIODEGRADABLE METAL-CHELATING POLYMERS AND VACCINES
#37Macromolecular Delivery Systems for Non-Invasive Imaging, Evaluation and Treatment of Arthritis and Other Inflammatory Diseases
#38Polymers
#39Macromolecular delivery systems for non-invasive imaging, evaluation and treatment of arthritis and other inflammatory diseases
#40Magnetic resonance imaging contrast agents synthesized using ring-opening metathesis polymerization
#41Degradable nanogel for drug delivery
#42Conjugated macromolecules
#43Chemical exchange saturation transfer contrast agents
#44Side-chain crystallizable polymers for medical applications
#45Method for assessing tumor response to cancer treatment
#46Compositions for detecting hyaluronidase activity in situ and methods of utilizing same
#47Magnetic resonance imaging agents for the detection of physiological agents